Mitomycin Injection, Powder, Lyophilized, For Solution
Product Images NDC 72819-154

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Mitomycin (NDC 72819-154). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Archis Pharma Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Image 01)

Chemical structure of Mitomycin, showing its molecular composition with rings and attached functional groups consistent with the drug Mitomycin.*

FDA Label Image

5mg Label (Image 2)

Mitomycin 5 mg/vial injection, powder, lyophilized for intravenous use. The label includes dosing details, storage instructions, and a warning to administer intravenously to avoid tissue damage. It is a single-dose vial supplied by Archis Pharma LLC, with directions for reconstitution and handling.*

FDA Label Image

20mg Label (Image 3)

Mitomycin 20 mg/vial injection, USP powder for solution by Archis Pharma LLC is shown on the carton label. The label indicates lyophilized powder for intravenous use only, with instructions for dilution and handling warnings. The package contains a single-dose vial of 20 mg/vial strength. Storage and usage details, including temperature and light protection, are also visible on the label.*

FDA Label Image

40mg Label (Image 4)

Mitomycin for Injection, USP 40 mg/vial label for a sterile, single-dose vial. The lyophilized powder is for intravenous use and requires reconstitution with 80 mL sterile water for injection. The label includes warnings, storage instructions, and distributor information for Archis Pharma LLC, Piscataway, NJ. The product is made in India.*

FDA Label Image

5mg Carton (Image 5)

Packaging label for Mitomycin for Injection, USP 5 mg/vial, a lyophilized powder for intravenous use. The label highlights warnings about intravenous administration and cytotoxic handling, storage instructions, and that the product is sterile and single-dose. It is distributed by Archis Pharma LLC and made in India.*

FDA Label Image

20mg Carton (Image 6)

Packaging label for Mitomycin injection, USP 20 mg/vial by Archis Pharma LLC. The label indicates the drug is lyophilized powder for solution, sterile, single-dose vial, for intravenous use. It includes warnings about intravenous administration to avoid tissue damage and cytotoxic handling precautions. Storage and dosage instructions are also present. The label displays barcodes, the labeler information, and regulatory details.*

FDA Label Image

40mg Carton (Image 7)

Packaging label for Mitomycin injection, USP 40 mg per vial, lyophilized powder for intravenous solution. The label includes warnings about intravenous administration and cytotoxic special handling instructions. Distributed by Archis Pharma LLC, the single-dose vial requires dilution before use. The label also provides reconstitution instructions and storage conditions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.